The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study
Abstract The aim of this study was to investigate the effect of Crocin on the inflammatory cytokines profile in patients with Metabolic syndrome (Mets). Twenty-eight patients with Mets (15 cases and 13 controls) were randomly selected by the International Diabetes Federation (IDF) definite criteria...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-15953-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849736225461633024 |
|---|---|
| author | Razie Rezaiee Hamideh Ghazizadeh Susan Darroudi Roshanak Ghaffarian Zirak Mohadese Rohban Marziyeh Eidi Irandokht Nikbakht Jam Ali Asghar Mahmoudi Farzin Hadizadeh Malihe Aghasizadeh Abbas Mohtashamian Majid Ghayour-Mobarhan |
| author_facet | Razie Rezaiee Hamideh Ghazizadeh Susan Darroudi Roshanak Ghaffarian Zirak Mohadese Rohban Marziyeh Eidi Irandokht Nikbakht Jam Ali Asghar Mahmoudi Farzin Hadizadeh Malihe Aghasizadeh Abbas Mohtashamian Majid Ghayour-Mobarhan |
| author_sort | Razie Rezaiee |
| collection | DOAJ |
| description | Abstract The aim of this study was to investigate the effect of Crocin on the inflammatory cytokines profile in patients with Metabolic syndrome (Mets). Twenty-eight patients with Mets (15 cases and 13 controls) were randomly selected by the International Diabetes Federation (IDF) definite criteria in a double-blind randomized clinical trial. Participants were divided into two treatment groups, a group received 15 mg of Crocin (two tablets per day), and the other one received a placebo for eight weeks. Inflammatory and growth factors were measured using a sandwich chemiluminescence assay, before and after treatment. Our results indicated that inflammatory factors including IL-2, IL-10, VEGF and INF γ, were significantly reduced (P < 0.05) in patients with Mets after Crocin treatment. Moreover, no significant difference was detected among the other biochemical factors (lipid profile and FBG) between two groups. The results showed the exclusive impact of Crocin on the reduction of serum inflammatory cytokines. Crocin has the potential to be further investigated as a useful therapeutic factor in inflammatory diseases. Clinical trial registration number: IRCT2013080514279N1, Registration date: 01/02/2015. |
| format | Article |
| id | doaj-art-55ef81bc17b44d22a57d0d018856d4d9 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-55ef81bc17b44d22a57d0d018856d4d92025-08-20T03:07:20ZengNature PortfolioScientific Reports2045-23222025-08-011511910.1038/s41598-025-15953-2The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial studyRazie Rezaiee0Hamideh Ghazizadeh1Susan Darroudi2Roshanak Ghaffarian Zirak3Mohadese Rohban4Marziyeh Eidi5Irandokht Nikbakht Jam6Ali Asghar Mahmoudi7Farzin Hadizadeh8Malihe Aghasizadeh9Abbas Mohtashamian10Majid Ghayour-Mobarhan11Metabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesBiotechnology Research Center, School of Pharmacy, Mashhad University of Medical SciencesStudent Research Committee, Faculty of Medicine, Mashhad University of Medical SciencesStudent Research Committee, Faculty of Medicine, Mashhad University of Medical SciencesMetabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical SciencesAbstract The aim of this study was to investigate the effect of Crocin on the inflammatory cytokines profile in patients with Metabolic syndrome (Mets). Twenty-eight patients with Mets (15 cases and 13 controls) were randomly selected by the International Diabetes Federation (IDF) definite criteria in a double-blind randomized clinical trial. Participants were divided into two treatment groups, a group received 15 mg of Crocin (two tablets per day), and the other one received a placebo for eight weeks. Inflammatory and growth factors were measured using a sandwich chemiluminescence assay, before and after treatment. Our results indicated that inflammatory factors including IL-2, IL-10, VEGF and INF γ, were significantly reduced (P < 0.05) in patients with Mets after Crocin treatment. Moreover, no significant difference was detected among the other biochemical factors (lipid profile and FBG) between two groups. The results showed the exclusive impact of Crocin on the reduction of serum inflammatory cytokines. Crocin has the potential to be further investigated as a useful therapeutic factor in inflammatory diseases. Clinical trial registration number: IRCT2013080514279N1, Registration date: 01/02/2015.https://doi.org/10.1038/s41598-025-15953-2Randomized double-blind clinical trialSaffronCytokines concentrationMetabolic syndrome |
| spellingShingle | Razie Rezaiee Hamideh Ghazizadeh Susan Darroudi Roshanak Ghaffarian Zirak Mohadese Rohban Marziyeh Eidi Irandokht Nikbakht Jam Ali Asghar Mahmoudi Farzin Hadizadeh Malihe Aghasizadeh Abbas Mohtashamian Majid Ghayour-Mobarhan The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study Scientific Reports Randomized double-blind clinical trial Saffron Cytokines concentration Metabolic syndrome |
| title | The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study |
| title_full | The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study |
| title_fullStr | The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study |
| title_full_unstemmed | The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study |
| title_short | The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study |
| title_sort | impacts of crocin on serum cytokines concentrations in participants with metabolic syndrome a double blind randomized clinical trial study |
| topic | Randomized double-blind clinical trial Saffron Cytokines concentration Metabolic syndrome |
| url | https://doi.org/10.1038/s41598-025-15953-2 |
| work_keys_str_mv | AT razierezaiee theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT hamidehghazizadeh theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT susandarroudi theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT roshanakghaffarianzirak theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT mohadeserohban theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT marziyeheidi theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT irandokhtnikbakhtjam theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT aliasgharmahmoudi theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT farzinhadizadeh theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT maliheaghasizadeh theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT abbasmohtashamian theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT majidghayourmobarhan theimpactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT razierezaiee impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT hamidehghazizadeh impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT susandarroudi impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT roshanakghaffarianzirak impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT mohadeserohban impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT marziyeheidi impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT irandokhtnikbakhtjam impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT aliasgharmahmoudi impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT farzinhadizadeh impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT maliheaghasizadeh impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT abbasmohtashamian impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy AT majidghayourmobarhan impactsofcrocinonserumcytokinesconcentrationsinparticipantswithmetabolicsyndromeadoubleblindrandomizedclinicaltrialstudy |